Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

61 results about "Phlebothrombosis" patented technology

Phlebothrombosis occurs when a blood clot (thrombosis) in a vein (phlebo) forms independently from the presence of inflammation of the vein (phlebitis). Thrombophlebitis is phlebitis (vein inflammation) related to a thrombus (blood clot). These conditions are usually of the superficial veins and are generally mild and uncomplicated as opposed to deep vein thromboses, which can be life-threatening.

Decoction for promoting blood circulation

The invention relates to a decoction for promoting blood circulation, which is prepared from the following raw materials in parts by weight: 15 to 25 parts of honeysuckle stem, 25 to 35 parts of glabrous greenbrier rhizome, 10 to 20 parts of Chinese angelica, 15 to 25 parts of root of rehmannia, 15 to 25 parts of red paeony root, 4 to 8 parts of peach seed, 6 to 12 parts of safflower, 6 to 12 parts of Chinese thorowax root, 6 to 12 parts of szechuan lovage rhizome, 8 to 16 parts of medicinal cyathula root, 15 to 25 parts of Chinese waxgourd peel, 6 to 14 parts of plantain seed, 4 to 8 parts of ricepaperplant pith, and 15 to 25 parts of suberect spatholobus stem. The decoction has the advantages that the Chinese medicament has the obvious functions of promoting blood circulation by removing blood stasis, expelling wind and removing damness, and relaxing tendons and strengthening bones. The decoction has a simple preparation process, is convenient to use, has a short course of treatment, a significant curative effect and a low price, and has good curative effect of treating limb pains, swelling, superficial venous engorgement and touchable cord-shaped objects along with veins caused by phlebothrombosis; and by taking the decoction, patients with mild symptoms can be cured in 20 days, and most patients with severe symptoms can be cured through two courses of treatment. The Chinese medicament is taken orally, and has no toxic or side effects.
Owner:李燕宁

Human phlebothrombosis risk gene F5 and PAI-1 polymorphism detection kit as well as preparation method and application thereof

The invention eblogns to the technical field of biology and specifically relates to a human phlebothrombosis risk gene F5 and PAI-1 polymorphism detection kit as well as a preparation method and application thereof. The kit is prepared from a detection reagent, a positive control product and a negative control product, wherein the detection reagent is used for amplifying gene F5 and PAI-1 polymorphism related to the human phlebothrombosis risk, wherein the detection reagent applied to the F5 gene polymorphism is prepared from a primer sequence, a PNA sequence and PCR reaction liquid; the primer sequence is used for amplifying an rs6025 site of F5 gene; the detection reagent applied to the PAI-1 gene polymorphism is prepared from a primer sequence, a PNA sequence and PCR reaction liquid; the primer sequence is used for amplifying an rs17999762 site of the PAI-1 gene. The kit disclosed by the invention is used for detecting the human aspirin resistance gene polymorphism and has the advantages of high flexibility, high specificity, convenience in operation, reliable results and the like; furthermore, detection can be finished within 1 hour, and result reading is simple and objective.
Owner:WUHAN HEALTHCHART BIOLOGICAL TECH

Formula for treating phlebothrombosis and preparation method thereof

InactiveCN101732690AWarming yang and dispelling dampnessHas heat-clearing and expelling windBlood disorderCardiovascular disorderMyrrhSaposhnikovia
The invention discloses a formula for treating phlebothrombosis and a preparation method thereof. The formula for treating the phlebothrombosis in the invention comprises the following raw materials in part by weight: 20 to 40 parts of white paeony root; 20 to 40 parts of common anemarrhena rhizome; 20 to 40 parts of divaricate saposhnikovia root; 10 to 20 parts of astraolylis lancea formalyrata; 10 to 20 parts of cassia twig; 10 to 20 parts of radix stephaniae tetrandrae; 10 to 20 parts of blast-fried aconite; 10 to 20 parts of amur corktree bark; 5 to 15 parts of ephedra herb; 5 to 15 parts of liquoric root; 5 to 15 parts of fresh ginger; 10 to 20 parts of atraotydin; 50 to 70 parts of coix seed; 50 to 70 parts of honeysuckle flower; 10 to 20 parts of peach seed; 5 to 15 parts of safflower; 5 to 15 parts of sappan wood; 5 to 15 parts of diverse wormwood herb; 10 to 20 parts of myrrh; and 5 to 15 parts of frankincense. The preparation method for the formula for treating the phlebothrombosis comprises the step that when the total mass of the raw materials is 395 grams, the volume of a medicament liquid prepared by decocting the raw materials is between 1,400 and 1,500 ml. The formula for treating the phlebothrombosis has effects of warming yang and eliminating dampness, removing heat and expelling wind, and eliminating slough and promoting granulation.
Owner:曹斌

Traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and preparation method of traditional Chinese medicine composition

The invention relates to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition disclosed by the invention is prepared from the following raw materials in weight ratio: ligusticum wallichii, the root of red-rooted salvia, leech, pangolin, fructus amomi, centipede, caulis Spatholobi, lycopodium clavatum, poria cocos, oldenlandia diffusa, oriental wormwood, frankincense, astragalus membranaceus, dandelion, liquorice, honeysuckle, safflower carthamus, peach kernel, Chinese angelica, the fruit of Chinese wolfberry, pericarpium citri reticulatae, lumbricus, medicated leaven, golden cypress, radix paeoniae alba and semen coicis. The traditional Chinese medicine composition disclosed by the invention is the pure traditional Chinese medicine preparation, has the advantages of low cost, obvious curative effect, steady pharmacological effect, no toxic and side effect and adverse reaction and non-recurrent after healing, and is simple to prepare and has wide market application prospect.
Owner:贾爱玲

Floor type wheel control mouse

The invention relates to a mouse, in particular to a floor type wheel control mouse with the advantages of simpler operation, more convenient use, more accurate control and durability in use. The floor type wheel control mouse comprises a mouse body, a base, a mouse photoelectric control circuit, a photoelectric signal acquisition hole, a left key, a right key, a middle key, a pedal wheel and a rolling tube, wherein the left key and the right key are arranged in the left part of the mouse body; the pedal wheel and the middle key are arranged in the right part of the mouse body; the rolling tube is integrated with the pedal wheel; and the center of the rolling tube is provided with a middle shaft which is fixed on a middle shaft support fixed on the base. Because the mouse is operated by feet instead of hands, the mouse not only can save time, improve work efficiency, but also is in favour of physical and mental health, and prevents diseases, such as carpal tunnel syndrome, tennis elbow, haemorrhoids, legs paralysis, phlebothrombosis, and on the like. When the mouse is used, people do not need to take off and change the shoes and worry about infecting barbiers. The invention has the advantage of more simple, convenient, reasonable, reliable and accurate operation. Besides, because dust on the floor is not easy to get in the circuit, the mouse is not easy to break down, and the like.
Owner:众为先(厦门)科技有限公司

Pure traditional Chinese medicine preparation for treating varicosity

The invention provides a pure traditional Chinese medicine preparation for treating varicosity. The pure traditional Chinese medicine preparation is prepared from the following traditional Chinese medicine raw materials: taraxacum mongolicum, cattail pollen, sophora japonica, centella asiatica, lycium barbarum, cortex dictamni, siberian walking fern, oroxylum indicum, wild chrysanthemum flower, mulberry twigs, excoecaria acerifclia, angelica citriodora, rhizoma nerdostachyos, rhizoma arisaematis, lithospermum, air potato, gentiana macrophylla, radix achyranthis, bulbophyllum inconspicuum, spina date seeds, fleshfingered citron flower, rubia cordifolia, melandrium album, thalictrum foliolosum, cactus, abrus cantoniensis hance and pyrolusite pyrolusitum. The invention aims to provide the pure traditional Chinese medicine preparation for treating varicosity, normal working, learning and living of patients are not affected in the treatment process, and the pure traditional Chinese medicine preparation has the advantages of no pain, no damage, high recovery property, high treatment effect and no reoccurrence after treatment, metabolism of partial cell tissue can be improved, phlebothrombosis and venous blood wall deposition residues can be rapidly dissolved and removed, yin and yang can be balanced to activate blood vessel wall and remedy wall membrane, convex superficial veins can be remedied, original skin color can be recovered, and the pure traditional Chinese medicine has a miraculous treatment effect on varicosity and complication.
Owner:代义壮

A human venous thrombosis risk gene f5 and pai-1 polymorphism detection kit and its preparation method and application

The invention eblogns to the technical field of biology and specifically relates to a human phlebothrombosis risk gene F5 and PAI-1 polymorphism detection kit as well as a preparation method and application thereof. The kit is prepared from a detection reagent, a positive control product and a negative control product, wherein the detection reagent is used for amplifying gene F5 and PAI-1 polymorphism related to the human phlebothrombosis risk, wherein the detection reagent applied to the F5 gene polymorphism is prepared from a primer sequence, a PNA sequence and PCR reaction liquid; the primer sequence is used for amplifying an rs6025 site of F5 gene; the detection reagent applied to the PAI-1 gene polymorphism is prepared from a primer sequence, a PNA sequence and PCR reaction liquid; the primer sequence is used for amplifying an rs17999762 site of the PAI-1 gene. The kit disclosed by the invention is used for detecting the human aspirin resistance gene polymorphism and has the advantages of high flexibility, high specificity, convenience in operation, reliable results and the like; furthermore, detection can be finished within 1 hour, and result reading is simple and objective.
Owner:WUHAN HEALTHCHART BIOLOGICAL TECH

External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method

The invention belongs to the medicine technical field, in particular to an external medicine for curing a limb venous thrombus and phlebitis. The invention is characterized in that bean powder, pawpaw powder, myrrh powder, china root powder and radix arnebiae form loose powder according to the weight proportion of 80 to 85 percent, 7 to 8 percent, 2.5 to 4.5 percent, 3 to 5.5 percent and 2.5 to 3.5 percent respectively are taken to form loose powder and prepared into the invention via the following method: dry bean, dry pawpaw, dry myrrh, dry china root and dry radix arnebiae are taken to be broken into powder to make bean powder, pawpaw powder, myrrh powder, china root powder and radix arnebiae powder over 80 meshed sieve. The loose powder is made by mixing the components equably according to the above weight proportion after 10 to 20 minutes of sterilization treatment. The loose powder is filled in the inner seal of a medical plastic bag by 348g to 352g. When in use, the loose powder of 348g to 352g and 500 millilitre magnesium sulphate solution with the chroma of 5 to 20 percent are mixed into paste. The invention has the advantages of simple production art, scientific and reasonable prescription, accurate and obvious curative effect, short period of treatment, no pain and side effect to human body, low price and convenient treatment as a Chinese patent medicine, and is worthy to be promoted.
Owner:莱芜钢铁集团有限公司医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products